US diagnostics firm to invest €10m in east Clare site
Of With Diagnostics Picture: Operations Kevin Eu Michael Coulter Lawler, and Orlaith Designate President Arthur Ellis Beckman Vice O’reilly Mcgrath
President Missioner
US biomedical firm Beckman Coulter Diagnostics has announced a €10m investment in its site in Co Clare, which will go towards upgrading the facility’s infrastructure, boosting both efficiency and capacity.
The California headquartered company employs more than 11,000 people worldwide — 550 of which are located at its east Clare site.
The company is actively hiring for 50 open roles but it also announced that it is seeking to add another 30 jobs to be recruited between 2025 and 2027.
The jobs are in areas such as production operations, quality and regulatory affairs, as well as research and development.
The company added that the investment will also go towards two new “fully automated reagent filling lines”.
Beckman Coulter has had a presence in Co Clare since 2005.
The current president of the company is Kevin O’Reilly who is originally from Ireland.
“I'm incredibly happy about Beckman Coulter's significant contributions to my home country, Ireland, not only to the local economy but also to enhancing healthcare every day,” Mr O’Reilly said.
Former finance minister and EU Commissioner-designate Michael McGrath, who was at the announcment, said Beckman Coulter is “a superb case study of the impact of foreign direct investment in Ireland, including into rural communities”.
“There are few settings more rural for foreign direct investment than this site in East Clare. Yet the Beckman Coulter produces cutting-edge diagnostic tools here that are critical to the delivery of healthcare across the globe and at the same time makes a massive economic impact on this area,” he said.